TGFB1 and chronic obstructive pulmonary disease: For instance, Minagawa et al. confirmed that inhibiting TGF-β activation using avβ8 antibodies effectively prevents fibroblast activation in the airways of patients with chronic obstructive pulmonary disease (Minagawa et al. 2014).